CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 5 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,466,766 | +22.4% | 310,764 | -0.0% | 0.90% | +3.4% |
| Q2 2023 | $6,914,655 | +4.7% | 310,771 | +1.9% | 0.88% | +22.2% |
| Q1 2023 | $6,606,864 | +6.2% | 305,026 | -0.4% | 0.72% | +1.6% |
| Q4 2022 | $6,220,466 | -19.0% | 306,276 | +2.2% | 0.70% | -17.4% |
| Q3 2022 | $7,681,000 | +7.7% | 299,576 | -0.1% | 0.85% | +13.7% |
| Q2 2022 | $7,129,000 | +9.3% | 299,780 | +3.5% | 0.75% | +22.1% |
| Q1 2022 | $6,522,000 | +15.4% | 289,625 | +1.5% | 0.61% | +18.5% |
| Q4 2021 | $5,650,000 | +0.5% | 285,342 | -0.1% | 0.52% | -1.5% |
| Q3 2021 | $5,621,000 | -9.4% | 285,642 | +1.3% | 0.53% | -9.6% |
| Q2 2021 | $6,203,000 | +10.5% | 281,962 | +19.5% | 0.58% | -0.3% |
| Q1 2021 | $5,615,000 | -2.9% | 236,041 | +6.8% | 0.58% | -11.2% |
| Q4 2020 | $5,783,000 | +54.1% | 221,045 | +2.5% | 0.66% | +28.3% |
| Q3 2020 | $3,753,000 | +13.2% | 215,630 | +9.4% | 0.51% | +4.9% |
| Q2 2020 | $3,316,000 | +37.7% | 197,140 | -2.6% | 0.49% | +16.2% |
| Q1 2020 | $2,408,000 | – | 202,497 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |